Found: 10
Select item for more details and to access through your institution.
Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2042, doi. 10.1002/1878-0261.13156
- By:
- Publication type:
- Article
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2057, doi. 10.1002/1878-0261.13188
- By:
- Publication type:
- Article
Clinical significance of circulating tumor cells and cell-free DNA in pediatric rhabdomyosarcoma.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2071, doi. 10.1002/1878-0261.13197
- By:
- Publication type:
- Article
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2031, doi. 10.1002/1878-0261.13178
- By:
- Publication type:
- Article
Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2000, doi. 10.1002/1878-0261.13214
- By:
- Publication type:
- Article
High CD34 surface expression in BCP-ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2015, doi. 10.1002/1878-0261.13207
- By:
- Publication type:
- Article
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2086, doi. 10.1002/1878-0261.13196
- By:
- Publication type:
- Article
Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 1986, doi. 10.1002/1878-0261.13170
- By:
- Publication type:
- Article
Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2098, doi. 10.1002/1878-0261.13157
- By:
- Publication type:
- Article
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 1969, doi. 10.1002/1878-0261.13150
- By:
- Publication type:
- Article